Il Sole 24 ore - pag. 22, March 7, 2011
Zcube, research venture of the Italian pharmaceutical Zambon Group, has signed with Desai Lab-University of California San Francisco (UCSF) an exclusive licensing agreement for the use of nanotechnology that allows the drug taken orally to be released in a controlled manner directly in the vicinity of the internal organs target of treatment. For the next two years will support research Zcube Lab Desai, who is working on the architecture of the carrier material and the drug nanotech.
0 comments:
Post a Comment